Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Titel:
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Auteur:
Mizokami, Masashi Yokosuka, Osamu Takehara, Tetsuo Sakamoto, Naoya Korenaga, Masaaki Mochizuki, Hitoshi Nakane, Kunio Enomoto, Hirayuki Ikeda, Fusao Yanase, Mikio Toyoda, Hidenori Genda, Takuya Umemura, Takeji Yatsuhashi, Hiroshi Ide, Tatsuya Toda, Nobuo Nirei, Kazushige Ueno, Yoshiyuki Nishigaki, Yoichi Betular, Juan Gao, Bing Ishizaki, Akinobu Omote, Masa Mo, Hongmei Garrison, Kim Pang, Phillip S Knox, Steven J Symonds, William T McHutchison, John G Izumi, Namiki Omata, Masao